Form 4: INSMED Chief Legal Officer Sells Shares for Tax Obligations and Under Pre-Arranged Plan

INSMED Inc.'s Chief Legal Officer, Michael Alexander Smith, reported two separate sales of common stock totaling 1,681 shares in July 2025, primarily to cover tax withholding and pursuant to a Rule 10b5-1 trading plan.

Summary

• Michael Alexander Smith, Chief Legal Officer of INSMED Inc. (INSM), reported changes in his beneficial ownership of common stock.
• On July 11, 2025, Mr. Smith sold 748 shares of common stock at a price of $96.41 per share.
• This sale was conducted to satisfy tax withholding obligations upon the vesting of Restricted Stock Units and to cover related broker fees.
• Following this transaction, Mr. Smith beneficially owned 67,327 shares of common stock.
• On July 15, 2025, an additional 933 shares of common stock were sold at a weighted average price of $102.51 per share, with prices ranging from $102.37 to $102.70.
• This second transaction was executed pursuant to a Rule 10b5-1 trading plan, which Mr. Smith adopted on February 27, 2025.
• After both reported transactions, Mr. Smith's beneficial ownership stands at 66,394 shares of common stock.
• His total beneficial ownership includes 357 shares acquired through the Company's 2018 Employee Stock Purchase Plan.

Sentiment

Score: 6

Explanation: The document reports routine insider stock sales, one for tax obligations and another under a pre-arranged 10b5-1 plan. These are common occurrences and do not inherently signal negative sentiment, leaning slightly positive due to the transparency of the 10b5-1 plan.

Positives

• One of the stock sales was conducted under a Rule 10b5-1 trading plan, adopted on February 27, 2025, which indicates a pre-planned, non-discretionary transaction, enhancing transparency and mitigating concerns about trading on material non-public information.

Negatives

• The transactions represent a reduction in the Chief Legal Officer's direct beneficial ownership of INSMED common stock by a total of 1,681 shares.

Future Outlook

No forward-looking statements or guidance are provided in this document.

Management Comments

• Shares were sold to satisfy tax withholding obligations upon the vesting of Restricted Stock Units and to cover related broker fees.
• One transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on February 27, 2025, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

Industry Context

This document reports routine insider stock transactions and does not provide information related to broader industry trends or competitive landscape.

Stakeholder Impact

• Shareholders: The sale of shares by a key executive slightly reduces insider ownership, which is a common occurrence and generally has minimal direct impact on share price unless the volume is unusually high or signals a lack of confidence. The use of a 10b5-1 plan for one sale provides transparency.

Key Dates

Keywords

INSMED Inc., INSM, Form 4, insider trading, stock sale, Michael Alexander Smith, Chief Legal Officer, 10b5-1 plan, equity, restricted stock units, tax withholding